Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Stinker

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jul 23, 2024 11:12am

62 Views

Post# 36144292

RE:RE:RE:RE:RE:RE:RE:RE:Stinker

Can you see how far down the rabbit hole you have to keep digging to justify your position?

Again....... read the information from the link I sent you and then verify each aspect with your own research. Don't trust any 1 source!!!! If the preponderance of evidence suggests a truth then there you go.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks